Published in Cancer Res on July 01, 2002
Cooperation between the Hic1 and Ptch1 tumor suppressors in medulloblastoma. Genes Dev (2008) 1.42
DNA methylation of developmental genes in pediatric medulloblastomas identified by denaturation analysis of methylation differences. Proc Natl Acad Sci U S A (2009) 1.26
Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients. Neoplasia (2009) 1.25
Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomas. Neoplasia (2005) 1.24
Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastoma. Nucleic Acids Res (2007) 1.19
HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors. Int J Biochem Cell Biol (2008) 1.13
Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective. Neuro Oncol (2008) 1.12
Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells. Mol Cell Biol (2010) 1.11
Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma. J Mol Diagn (2004) 1.05
Scavenger chemokine (CXC motif) receptor 7 (CXCR7) is a direct target gene of HIC1 (hypermethylated in cancer 1). J Biol Chem (2009) 1.01
The tumor suppressor gene KCTD11REN is regulated by Sp1 and methylation and its expression is reduced in tumors. Mol Cancer (2010) 0.97
Mouse models of medulloblastoma. Chin J Cancer (2011) 0.94
Hypermethylated in cancer 1 (HIC1) recruits polycomb repressive complex 2 (PRC2) to a subset of its target genes through interaction with human polycomb-like (hPCL) proteins. J Biol Chem (2012) 0.93
The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1). J Biol Chem (2011) 0.93
Just say no to ATOH: how HIC1 methylation might predispose medulloblastoma to lineage addiction. Cancer Res (2008) 0.86
The molecular genetics of medulloblastoma: an assessment of new therapeutic targets. Neurosurg Rev (2008) 0.85
Epigenetics of neurological cancers. Future Oncol (2009) 0.85
Deciphering HIC1 control pathways to reveal new avenues in cancer therapeutics. Expert Opin Ther Targets (2013) 0.84
Matching mice to malignancy: molecular subgroups and models of medulloblastoma. Childs Nerv Syst (2012) 0.83
Recent advances in embryonal tumours of the central nervous system. Childs Nerv Syst (2005) 0.82
Identification of novel subregions of LOH in gastric cancer and analysis of the HIC1 and TOB1 tumor suppressor genes in these subregions. Mol Cells (2011) 0.82
Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma. Oncotarget (2015) 0.81
Signification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression. Cancer Microenviron (2012) 0.81
Deregulated proliferation and differentiation in brain tumors. Cell Tissue Res (2014) 0.80
Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies. Childs Nerv Syst (2006) 0.78
Differential SKIP expression in PTEN-deficient glioblastoma regulates cellular proliferation and migration. Oncogene (2014) 0.76
HIC1 Expression Distinguishes Intestinal Carcinomas Sensitive to Chemotherapy. Transl Oncol (2016) 0.75
Reactivation of HIC-1 gene by saRNA inhibits clonogenicity and invasiveness in breast cancer cells. Oncol Lett (2014) 0.75
HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1. Sci Rep (2016) 0.75
Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinoma. Oncotarget (2016) 0.75
Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway. Oncotarget (2016) 0.75
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. J Hepatol (2010) 2.65
miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer. Gut (2011) 1.66
Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors. Oncologist (2003) 1.24
Elevated oncofoetal miR-17-5p expression regulates colorectal cancer progression by repressing its target gene P130. Nat Commun (2012) 1.21
Overexpression of miR-21 in patients with ulcerative colitis impairs intestinal epithelial barrier function through targeting the Rho GTPase RhoB. Biochem Biophys Res Commun (2013) 0.96
Clear cell renal cell carcinoma: contrast-enhanced ultrasound features relation to tumor size. Eur J Radiol (2008) 0.94
RNA interference targeting CML66, a novel tumor antigen, inhibits proliferation, invasion and metastasis of HeLa cells. Cancer Lett (2008) 0.90
Detection of human herpesvirus-6 variants in pediatric brain tumors: association of viral antigen in low grade gliomas. J Clin Virol (2009) 0.90
Unsaturated cationic ortho esters for endosome permeation in gene delivery. J Med Chem (2007) 0.89
Primary clear cell sarcoma of humerus: case report. World J Surg Oncol (2011) 0.89
Identification of changes in wheat (Triticum aestivum L.) seeds proteome in response to anti-trx s gene. PLoS One (2011) 0.87
Contrast-enhanced harmonic ultrasonography for the assessment of prostate cancer aggressiveness: a preliminary study. Korean J Radiol (2009) 0.86
The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age. Contraception (2010) 0.82
Association of dental fluorosis with polymorphisms of estrogen receptor gene in Chinese children. Biol Trace Elem Res (2010) 0.82
Identification of HSP27 as a potential tumor marker for colorectal cancer by the two-dimensional polyacrylamide gel electrophoresis. Mol Biol Rep (2009) 0.80
Postsurgical meningitis caused by Bordetella bronchiseptica. Pediatr Infect Dis J (2003) 0.80
Analysis of plant sterol and stanol esters in cholesterol-lowering spreads and beverages using high-performance liquid chromatography-atmospheric pressure chemical ionization-mass spectroscopy. J Agric Food Chem (2003) 0.79
Intercellular heterogeneity of expression of the MGMT DNA repair gene in pediatric medulloblastoma. Neuro Oncol (2004) 0.78
Combined buccal and lingual mucosa grafts for urethroplasty: an experimental study in dogs. J Surg Res (2009) 0.78
Benign looking giant cell component in dedifferentiated chondrosarcoma: benign or malignant? A case report. Int J Surg Pathol (2012) 0.78
Resveratrol inhibits VEGF gene expression and proliferation of hepatocarcinoma cells. Hepatogastroenterology (2014) 0.77
Novel pH-sensitive cationic lipids with linear ortho ester linkers for gene delivery. Eur J Med Chem (2012) 0.77
Hand-Schüller-Christian disease and Erdheim-Chester disease: coexistence and discrepancy. Oncologist (2013) 0.77
Malignant transformation in monostotic fibrous dysplasia: clinical features, imaging features, outcomes in 10 patients, and review. Medicine (Baltimore) (2015) 0.77
Inhibitory effect of resveratrol on the expression of the VEGF gene and proliferation in renal cancer cells. Mol Med Rep (2011) 0.77
An experimental study of colonic mucosal graft for urethral reconstruction. Chin Med J (Engl) (2002) 0.76
Carcinoma of the thyroid gland showing thymic-like elements: hypofunctioning nodule accumulating (99m)Tc-MIBI and (18)F-FDG. Hell J Nucl Med (2011) 0.76
[Measurement of 25-hydroxyvitamin D3 in human serum by liquid chromatography-tandem mass spectrometry and the control for analytical conditions]. Wei Sheng Yan Jiu (2012) 0.75
Luminescence 3D-ordered porous materials composed of CdSe and CdTe nanocrystals. J Phys Chem B (2005) 0.75
[Serum carotenoid concentrations in some Chinese adults from urban, suburban and rural communities]. Wei Sheng Yan Jiu (2011) 0.75
[Study on DNA-protein crosslinks of certain organs of mice induced by microcystin-LR]. Wei Sheng Yan Jiu (2008) 0.75
[Influence of fluorine on expression of androgen-binding protein and inhibin B mRNA in rat testis sertoli cells]. Wei Sheng Yan Jiu (2010) 0.75
[Detection of the expression level of S100C gene in lung cancer tissue by RT-PCR and construction and identification of prokaryotic expression vector]. Wei Sheng Yan Jiu (2008) 0.75
[Liposclerosing myxofibrous tumor of bone: a clinicopathologic analysis]. Zhonghua Bing Li Xue Za Zhi (2016) 0.75
[Isolation and purification and toxigenic characteristic identification of microcystis]. Wei Sheng Yan Jiu (2007) 0.75
[Detection of the expression level of S100C gene in lung cancer tissue by RT-PCR and construction and identification of prokaryotic expression vector]. Wei Sheng Yan Jiu (2008) 0.75
[Characteristic analysis on the toxin of microcystis in life water source of Zhengzhou City]. Wei Sheng Yan Jiu (2007) 0.75
[Pathologic diagnosis and histogenesis of primary signet ring cell carcinoma of the prostate]. Zhonghua Bing Li Xue Za Zhi (2002) 0.75
[Removal effect of riverside pumping project on microcystins in the Yellow River]. Wei Sheng Yan Jiu (2010) 0.75
[Establishment of the predictive model of source eutrophication using artificial neural network]. Wei Sheng Yan Jiu (2008) 0.75